Celularity Inc Quarterly Income Tax Expense (Benefit) in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Celularity Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2019 to Q2 2024.
  • Celularity Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $0.000.
  • Celularity Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $10K.
  • Celularity Inc annual Income Tax Expense (Benefit) for 2023 was $10K, a 23.1% decline from 2022.
  • Celularity Inc annual Income Tax Expense (Benefit) for 2022 was $13K, a 35% decline from 2021.
  • Celularity Inc annual Income Tax Expense (Benefit) for 2021 was $20K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $10K $0 $0 Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 $10K $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-10-16
Q4 2023 $10K $10K -$3K -23.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-07-30
Q3 2023 $13K $0 +$17K Jul 1, 2023 Sep 30, 2023 10-Q 2024-01-03
Q2 2023 -$4K $0 -$17K -100% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 $13K $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-10-16
Q4 2022 $13K $13K Oct 1, 2022 Dec 31, 2022 10-K 2024-07-30
Q3 2022 -$17K Jul 1, 2022 Sep 30, 2022 10-Q 2024-01-03
Q2 2022 $17K -$26.7K -61.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $0 +$43.7K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q2 2021 -$4.93M $43.7K +$81.9K Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-19
Q1 2021 -$5.02M -$43.7K -$316K -116% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-24
Q4 2020 -$4.7M -$4.95M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $15K -$283K -95% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$38.2K -$207K -123% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-19
Q1 2020 $273K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
Q3 2019 $298K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $169K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.